Coral is a healthcare automation startup that aims to address the administrative challenges of the US healthcare market. Coral has raised $12.5 million in a new funding round. Z47 (formerly Matrix Partners India) and Lightspeed led this round. It indicated heavy venture capital attention to vertical AI applications in the medical back-office market.

The firm intends to use the newly acquired capital to expand its engineering and hire domain expertise in healthcare operations. This high-level recruitment will help this firm achieve its mission to remove the manual, error-prone workflows that presently characterized the administrative experience of many specialty providers.

Accuracy rate and philosophy of Coral

The US healthcare administrative space is currently infamous due to the use of outdated communication tools, especially manual coordination and paper-based fax machines. Coral was launched by Ajay Shrihari and Aniket Mohanty, both former IIT Hyderabad alumni and initially founding engineers at LimeChat, specifically to modernize these workflows. 

The platform will interface with current Electronic Health Records (EHRs) and payer portals. This philosophy of working with, not against, gives healthcare providers the option to automate their patient intake, prior authorizations, and insurance checks without necessarily having to reinvent their existing software infrastructure or shift their daily operational patterns.

The capability to process complex and unstructured data is one of the most notable aspects of Coral technology. The platform of the firm is capable of processing document processing of both handwritten faxes and scanned insurance cards with a reported accuracy of 99.7%. Such a high level of accuracy is essential in a profession where any small mistakes may result in a refusal of claims or stalling of patient treatment. 

Through the automation of these processes, Coral has been able to lower the time it took to perform complex types of patient intake, a process that once took 30 minutes, to just less than five minutes. This effectiveness not only optimizes the administrative pipeline but also shows that patients get the required authorizations and treatments significantly quicker compared to the traditional manual systems.

Strategic intelligence and expansion

Coral introduced its services in the traditional medical equipment (DME) segment, which is a branch of the outpatient segment that is especially encumbered by the necessity of aggressive faxing and documentation. Since the startup has demonstrated its model there, it has since further spread to infusion centers and specialty pharmacies. 

The high-order determinant in these verticals is the existence of drug-slow administrative slack that removes clinical staff from non-patient work. Coral is also expanding into even more specialized areas, such as radiology. This growth is informed by the platform, which can easily collaborate with various entities to access the missing data and handle cases regardless of the type of medical profession.

Coral is working on more sophisticated tools to deliver further value to healthcare operators. The market development activities are directed towards an AI-powered workflow builder today. It will enable providers to create and implement custom administrative automations without calling into IT for tickets or having technical coding knowledge. 

The company is developing a co-pilot layer that will surface actionable intelligence on the operational data that it processes. This layer will evaluate key business indicators, including which payers have the largest denial rates and which cases are languishing in the authorization process, enabling practice managers to make evidence-based decisions to enhance revenue and patient flow.

Conclusion

The $12.5 million investment in Coral is a major step in bringing contemporary AI and automation to the $1 trillion US healthcare administrative industry. By emphasizing the resolution of granular, high problem, high frequency issues such as fax processing and prior authorizations, Coral is producing immediate and quantifiable results to specialty providers.

Their support of premier investors such as Z47 and Lightspeed, along with their emphasis on engineering excellence and domain expertise, makes the corporation a core contributor to changing the healthcare back office. Coral will be crucial in eliminating the overall administrative burden that has long impaired the efficiency and scale of the global healthcare system as it continues to expand its activities and add new products, such as its AI workflow builder.